4 completed, 3 terminated, 1 active not recruiting. 8 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 4, Terminated 3, Active not recruiting 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Plasma Cell Neoplasm: new trials by email Literature Review of Plasma Cell Neoplasm trials Research Report on Plasma Cell Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma Radiation Therapy - Multiple Myeloma, Plasma Cell Neoplasm | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 30 | 2022-05-31 | 2026-10-06 |
| Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies Fludarabine, Cyclophosphamide, Total body irradiation - Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 117 | 2015-12-01 | 2022-11-03 |
| Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction Lenalidomide, Dexamethasone, Anticoagulants - Multiple Myeloma, Plasma Cell Neoplasm | Phase 1 / Phase 2 | Terminated | PrECOG, LLC. | 63 | 2009-01-21 | 2018-10-24 |
| Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction Human immune globulin intravenous (IGIV) - Multiple Myeloma, Plasma Cell Neoplasm | Phase 1 / Phase 2 | Completed | University of Tennessee | 10 | 2007-10-01 | 2013-09-19 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer anti-thymocyte globulin, G-CSF, busulfan - Leukemia, Lymphoma | Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 82 | 2002-12-01 | 2016-07-01 |
| Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy anti-thymocyte globulin, cyclophosphamide, cyclosporine - Kidney Cancer, Leukemia | Phase 2 | Terminated | Masonic Cancer Center, University of Minnesota | 342 | 2002-03-26 | 2020-05-12 |
| Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma filgrastim, CD34+ cells, cyclophosphamide - Multiple Myeloma, Plasma Cell Neoplasm | Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 60 | 2001-11-01 | 2016-07-04 |
| 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis filgrastim, melphalan, autologous stem cell transplantation - Multiple Myeloma, Plasma Cell Neoplasm | Phase 2 | Terminated | Boston Medical Center | 12 | 2001-08-01 | 2017-01-27 |
Multiple Myeloma (8) · Neoplasms, Plasma Cell (8) · Myelodysplastic Syndromes (3) · Immunoglobulin Light-chain Amyloidosis (2) · Leukemia (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Prolymphocytic (2) · Lymphoma (2) · Myeloproliferative Disorders (2) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Hodgkin Disease (1) · Kidney Neoplasms (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)
Blood Protein Disorders (8) · Cardiovascular Diseases (8) · Hematologic Diseases (8) · Hemic and Lymphatic Diseases (8) · Hemorrhagic Disorders (8) · Hemostatic Disorders (8) · Immune System Diseases (8) · Immunoproliferative Disorders (8) · Lymphoproliferative Disorders (8) · Neoplasms (8) · Neoplasms by Histologic Type (8) · Vascular Diseases (8) · Paraproteinemias (7) · Bone Marrow Diseases (3) · Lymphatic Diseases (3)
Filgrastim (4) · Granulocyte Colony-Stimulating Factor (4) · fludarabine phosphate (4) · Cyclophosphamide (3) · Mycophenolic Acid (3) · Tacrolimus (3) · Antilymphocyte Serum (2) · Melphalan (2) · Methotrexate (2) · Whole-Body Irradiation (2) · fludarabine (2) · Allopurinol (1) · Anticoagulants (1) · Aspirin (1) · Bone Marrow Transplantation (1)
Alliance for Clinical Trials in Oncology (2) · Boston Medical Center (1) · M.D. Anderson Cancer Center (1) · Masonic Cancer Center, University of Minnesota (1) · PrECOG, LLC. (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University of Tennessee (1)
United States (8)
Alan Solomon, MD (1) · Amy E DeZern, MD (1) · Asad Bashey, MD, PhD (1) · Erica Warlick, MD (1) · Joseph R. Mikhael, MD (1) · Karen Quillen, MD (1) · Kenneth C. Anderson, MD (1) · Penny Fang, MD (1)
PMID 19179301, PMID 20674758, PMID 21403127, PMID 22430088, PMID 30190454, PMID 32325171
U10CA031946 (2), P01CA015396 (1)